Aspen Aerogels (NYSE:ASPN) Hits New 52-Week High at $21.50

Aspen Aerogels, Inc. (NYSE:ASPN) reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as $21.50 and last traded at $20.57, with a volume of 2639176 shares traded. The stock had previously closed at $15.22.

Analyst Ratings Changes

ASPN has been the subject of a number of research analyst reports. B. Riley upped their price objective on shares of Aspen Aerogels from $24.00 to $30.00 and gave the company a “buy” rating in a research report on Friday. Canaccord Genuity Group upped their price target on Aspen Aerogels from $18.00 to $28.00 and gave the company a “buy” rating in a report on Friday. Roth Mkm reissued a “buy” rating and set a $22.00 price objective on shares of Aspen Aerogels in a report on Tuesday. TheStreet upgraded Aspen Aerogels from a “d+” rating to a “c-” rating in a research note on Wednesday, March 6th. Finally, HC Wainwright raised their target price on Aspen Aerogels from $20.00 to $25.00 and gave the stock a “buy” rating in a research report on Friday. One analyst has rated the stock with a sell rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, Aspen Aerogels currently has an average rating of “Moderate Buy” and a consensus target price of $25.17.

Aspen Aerogels Stock Performance

The company has a debt-to-equity ratio of 0.24, a quick ratio of 2.91 and a current ratio of 3.41. The firm has a 50 day moving average price of $16.72 and a two-hundred day moving average price of $13.69. The company has a market capitalization of $1.93 billion, a P/E ratio of -57.09 and a beta of 1.97.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings results on Tuesday, February 13th. The construction company reported ($0.01) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.11. Aspen Aerogels had a negative return on equity of 6.54% and a negative net margin of 10.73%. The firm had revenue of $84.22 million for the quarter, compared to analysts’ expectations of $83.82 million. During the same period in the prior year, the business posted ($0.20) earnings per share. On average, research analysts expect that Aspen Aerogels, Inc. will post -0.24 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Aspen Aerogels

A number of hedge funds have recently made changes to their positions in ASPN. AIGH Capital Management LLC bought a new position in Aspen Aerogels in the 3rd quarter valued at $15,067,000. Mesirow Institutional Investment Management Inc. bought a new position in shares of Aspen Aerogels in the fourth quarter valued at about $12,015,000. Rice Hall James & Associates LLC lifted its position in Aspen Aerogels by 385.0% during the 3rd quarter. Rice Hall James & Associates LLC now owns 623,135 shares of the construction company’s stock worth $5,359,000 after buying an additional 494,662 shares in the last quarter. Worth Venture Partners LLC bought a new stake in Aspen Aerogels during the 3rd quarter worth about $3,684,000. Finally, Federated Hermes Inc. increased its position in Aspen Aerogels by 53.9% in the 4th quarter. Federated Hermes Inc. now owns 1,154,042 shares of the construction company’s stock valued at $18,211,000 after acquiring an additional 404,042 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.